Connect Biopharma shares surge 11.89% intraday after being highlighted as promising penny stock in recent article.

Connect Biopharma surged 11.89% intraday after being highlighted in a report titled "Discovering Connect Biopharma Holdings And 2 Other Promising Penny Stocks," which positioned the stock as a potential growth opportunity. While the article’s content was not disclosed, its focus on the company as a "promising" penny stock likely attracted speculative buying, aligning with the sharp intraday price increase. The lack of detailed operational or financial updates in the news event suggests the move was driven by investor sentiment toward small-cap biopharma opportunities rather than specific corporate developments.